• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ductal carcinoma in situ: assessment of necrosis and nuclear morphology and their association with biological markers.

作者信息

Bobrow L G, Happerfield L C, Gregory W M, Millis R R

机构信息

ICRF Clinical Oncology Unit, Guy's Hospital, London, U.K.

出版信息

J Pathol. 1995 Aug;176(4):333-41. doi: 10.1002/path.1711760404.

DOI:10.1002/path.1711760404
PMID:7562248
Abstract

One hundred and five cases of pure ductal carcinoma in situ (DCIS) seen in the Guy's Hospital breast unit between 1975 and 1991 were reviewed. The presence and extent of necrosis and the degree of cytonuclear differentiation were assessed and the expression of p53 protein, cerbB2 protein, progesterone receptor, and a proliferation antigen KiS1, all factors reported to be of prognostic significance in invasive ductal carcinoma, was evaluated using immunohistochemical methods. A strong correlation was seen between the presence and extent of necrosis and the degree of cytonuclear differentiation and between both these morphological criteria and the biological markers as well as between the individual markers. The presence of extensive necrosis was associated with lack of cytonuclear differentiation and both were associated with a high proliferation rate, the presence of cerbB2 and p53 protein, and the absence of progesterone receptors. In cases with little or no necrosis, there was good nuclear differentiation and a strong correlation with the presence of progesterone receptor, absence of cerbB2 and p53 protein, and a low rate of proliferation.

摘要

相似文献

1
Ductal carcinoma in situ: assessment of necrosis and nuclear morphology and their association with biological markers.
J Pathol. 1995 Aug;176(4):333-41. doi: 10.1002/path.1711760404.
2
The classification of ductal carcinoma in situ and its association with biological markers.
Semin Diagn Pathol. 1994 Aug;11(3):199-207.
3
Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers.乳腺大汗腺导管原位癌:组织学分类及生物学标志物的表达
Hum Pathol. 2001 May;32(5):487-93. doi: 10.1053/hupa.2001.24327.
4
Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity.采用新分类法分析乳腺钼靶检测到的乳腺导管原位癌。127例研究:与雌激素和孕激素受体、p53和c-erbB-2蛋白以及增殖活性的相关性。
Semin Diagn Pathol. 1994 Aug;11(3):208-14.
5
Tumour markers in breast carcinoma correlate with grade rather than with invasiveness.乳腺癌中的肿瘤标志物与肿瘤分级相关,而非与侵袭性相关。
Br J Cancer. 2001 Sep 14;85(6):869-74. doi: 10.1054/bjoc.2001.1995.
6
Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.与组织蛋白酶D、基质溶解素-1、CD44、细胞外基质成分、P53、Rb、C-erbB-2、表皮生长因子受体、类固醇受体含量及增殖情况相比,金属硫蛋白在人乳腺癌中的免疫组织化学定位
Anticancer Res. 1999 May-Jun;19(3A):2133-9.
7
Ductal carcinoma in situ of the breast: correlation between histologic classifications and biologic markers.乳腺导管原位癌:组织学分类与生物学标志物之间的相关性
Mod Pathol. 1997 Nov;10(11):1088-92.
8
Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.病理学观点。乳腺导管原位癌:关于一种新的简化组织学分类以及细胞增殖与c-erbB-2蛋白表达之间关联的提议。
Mod Pathol. 1994 Feb;7(2):257-62.
9
Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.女性乳腺原位癌。一项临床病理、免疫组织化学及DNA倍体研究。
APMIS Suppl. 2003(108):1-67.
10
Correlation of p53 and cerbB2 expression and hormonal receptor status with clinicopathologic parameters in ductal carcinoma in situ of the breast.乳腺导管原位癌中p53、cerbB2表达及激素受体状态与临床病理参数的相关性
Oncol Rep. 2002 Sep-Oct;9(5):1081-6.

引用本文的文献

1
Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43.导管原位癌(DCIS)中集中 HER2 检测的初步结果:NSABP B-43。
Breast Cancer Res Treat. 2013 Nov;142(2):415-21. doi: 10.1007/s10549-013-2755-z. Epub 2013 Nov 8.
2
C-Erb-b2 oncogene expression in intraductal proliferative lesions of the breast.C-Erb-b2 癌基因在乳腺导管内增生性病变中的表达。
Bosn J Basic Med Sci. 2012 Feb;12(1):41-50. doi: 10.17305/bjbms.2012.2533.
3
Molecular grading of ductal carcinoma in situ of the breast.
乳腺导管原位癌的分子分级
Clin Cancer Res. 2008 Dec 15;14(24):8244-52. doi: 10.1158/1078-0432.CCR-08-0939.
4
COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ.环氧化酶-2(COX-2)的表达与导管原位癌的侵袭性表型相关。
Br J Cancer. 2004 Jan 26;90(2):423-9. doi: 10.1038/sj.bjc.6601534.
5
Thrombospondin 1 protein expression relates to good prognostic indices in ductal carcinoma in situ of the breast.血小板反应蛋白1蛋白表达与乳腺导管原位癌的良好预后指标相关。
J Clin Pathol. 2002 Dec;55(12):921-5. doi: 10.1136/jcp.55.12.921.
6
Androgen receptor expression in ductal carcinoma in situ of the breast: relation to oestrogen and progesterone receptors.乳腺导管原位癌中雄激素受体的表达:与雌激素和孕激素受体的关系。
J Clin Pathol. 2002 Jan;55(1):14-6. doi: 10.1136/jcp.55.1.14.
7
P53, apoptosis, and breast cancer.P53、细胞凋亡与乳腺癌
J Mammary Gland Biol Neoplasia. 1996 Apr;1(2):163-75. doi: 10.1007/BF02013640.
8
p53 mutations and expression in breast carcinoma in situ.原位乳腺癌中的p53突变与表达
Am J Pathol. 2000 Jan;156(1):183-91. doi: 10.1016/S0002-9440(10)64718-9.
9
Cytological and architectural heterogeneity in ductal carcinoma in situ of the breast.乳腺导管原位癌的细胞学和结构异质性。
J Clin Pathol. 1997 Jul;50(7):596-9. doi: 10.1136/jcp.50.7.596.
10
Mutation of the TP53 gene and allelic imbalance at chromosome 17p13 in ductal carcinoma in situ.导管原位癌中TP53基因的突变及17号染色体p13区域的等位基因失衡
Br J Cancer. 1996 Nov;74(10):1578-85. doi: 10.1038/bjc.1996.592.